Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Nuclear Medicine

• Publication date

  2002-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 11850478
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinson's disease

  2001cited by this paper
• Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.

  2001cited by this paper
• Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.

  2000cited by this paper
• Preclinical (premotor) Parkinson’s disease

  2000cited by this paper
• Preclinical Impairment of the Striatal Dopamine Transporter System in Sporadic Olivopontocerebellar Atrophy: Studied with [123I]β-CIT and SPECT

  2000cited by this paper
• Simplified quantification of dopamine transporters in humans using [99mTc]TRODAT-1 and single-photon emission tomography

  2000cited by this paper
• Pathoanatomy of Parkinson’s disease

  2000cited by this paper
• Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease

  2000cited by this paper
• Decreased dopamine transporter binding in Machado-Joseph disease.

  2000cited by this paper
• In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

  2000cited by this paper
• Regulation of dopaminergic activity in early Parkinson's disease

  1999cited by this paper
• Pathogenesis and preclinical course of Parkinson's disease.

  1999cited by this paper
• Preclinical diagnosis of Parkinson's disease.

  1999cited by this paper
• Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.

  1999cited by this paper
• Dopamine transporters and neuronal injury.

  1999cited by this paper
• Positron emission tomography in asymptomatic gene carriers of Machado-Joseph disease

  1998cited by this paper
• Progressive atrophy of cerebellum and brainstem as a function of age and the size of the expanded CAG repeats in the MJD1 gene in Machado‐Joseph disease

  1998cited by this paper
• The natural history of parkinson's disease

  1998cited by this paper
• The early diagnosis of parkinson's disease

  1998cited by this paper
• Imaging of dopamine transporters in humans with technetium-99m TRODAT 1

  1996cited by this paper
• Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging

  1996cited by this paper
• Decreased single‐photon emission computed tomographic {123I}β‐CIT striatal uptake correlates with symptom severity in parkinson's disease

  1995cited by this paper
• [The pathology of Joseph's disease in a Chinese family: a report of two autopsy cases].

  1994cited by this paper
• [The pathology of Joseph's disease in a Chinese family: a report of two autopsy cases].

  1994cited by this paper
• CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

  1994cited by this paper
• Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2 beta-carbomethoxy-3 beta-(4-chlorophenyl)tropanes: potential dopamine reuptake site imaging agents.

  1994cited by this paper
• Regression analysis for correlated data.

  1993cited by this paper
• Human Striatal l-DOPA Decarboxylase Activity Estimated in vivo Using 6-[18F]fluoro-DOPA and Positron Emission Tomography: Error Analysis and Application to Normal Subjects

  1993cited by this paper
• Joseph's disease: Clinical and pathological studies in a Japanese family

  1986cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• Joseph disease

  1982cited by this paper
• Striatonigral degeneration disputed in familial disorder

  1977cited by this paper
• Azorean disease of the nervous system.

  1977cited by this paper
• Azorean disease of the nervous system.

  1977cited by this paper
• Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia. A unique and partially treatable clinico-pathological entity.

  1972cited by this paper

• Role of Dual-Phase 18F FP-CIT PET for Subtyping of Multiple System Atrophy.

  2026cites this paper
• Hemichorea as the sole clinical manifestation of spinocerebellar ataxia type 8: a case report

  2025cites this paper
• Association between the use of levodopa/carbidopa, Alzheimer's disease biomarkers, and cognitive decline among participants in the National Alzheimer's Coordinating Center Uniform Data Set

  2025cites this paper
• The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI Cohort

  2025cites this paper
• The characteristic and biomarker value of transcranial sonography in cerebellar ataxia

  2024cites this paper
• Effect of levodopa/carbidopa on the progression of Machado-Joseph disease /spinocerebellar ataxia type 3 (MJD/SCA3)

  2024influential citation
• Altered brain white matter structural motor network in spinocerebellar ataxia type 3

  2022cites this paper
• Drug repurposing of dopaminergic drugs to inhibit Ataxin-3 aggregation

  2022cites this paper
• Clinically Meaningful Magnetic Resonance Endpoints Sensitive to Preataxic Spinocerebellar Ataxia Types 1 and 3

  2022cites this paper
• SPECT in der Diagnostik von Parkinson-Syndromen

  2020cites this paper
• 99mTc‐TRODAT‐1 SPECT Showing Dopaminergic Deficiency in a Patient with Spinocerebellar Ataxia Type 10 and Parkinsonism

  2018cites this paper
• Neuroimaging Applications in Chronic Ataxias.

  2018cites this paper
• Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation

  2018cites this paper
• The cerebral metabolic topography of spinocerebellar ataxia type 3

  2017cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Does degeneration of the subthalamic nucleus prevent parkinsonism in spinocerebellar ataxia type 2 and type 3?

  2015cites this paper
• No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.

  2015cites this paper
• Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease.

  2014cites this paper
• impairments in mouse models of Machado-Joseph disease

  2014cites this paper
• Neuroimaging of Ataxias

  2013cites this paper
• Caffeine and adenosine A2A receptor inactivation decrease striatal neuropathology in a lentiviral‐based model of Machado–Joseph disease

  2013influential citation
• Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease.

  2013cites this paper
• Sleep disorders in Machado-Joseph disease: a dopamine transporter imaging study.

  2013cites this paper
• Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders

  2012influential citation
• Dopamine Transporter Imaging for Distinguishing Between Idiopathic Parkinson’s Disease and Secondary Parkinsonism

  2012cites this paper
• Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study.

  2012cites this paper
• Mouse Models of Polyglutamine Diseases: Review and Data Table. Part I

  2012cites this paper
• MRI‐Texture Analysis of Corpus Callosum, Thalamus, Putamen, and Caudate in Machado‐Joseph Disease

  2012cites this paper
• Magnetic resonance and nuclear medicine imaging in ataxias.

  2012cites this paper
• The Role of Molecular Imaging in the Diagnosis and Management of Neuropsychiatric Disorders

  2011cites this paper
• Striatal dopamine function in a family with multiple SCA-3 phenotypes

  2011cites this paper
• Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3?

  2010cites this paper
• 123 IFP-CIT SPET striatal uptake in parkinsonian patients with the ·-synuclein ( G 209 A ) mutation

  2009cites this paper
• (123)I-FP-CIT SPET striatal uptake in parkinsonian patients with the alpha-synuclein (G209A) mutation A.

  2008cites this paper
• Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease.

  2008cites this paper
• The role of DAT-SPECT in movement disorders

  2008cites this paper
• Molecular genetics and biomarkers of polyglutamine diseases.

  2008cites this paper
• I-FP-CIT SPET striatal uptake in parkinsonian patients with the ·-synuclein (G209A) mutation

  2008cites this paper
• Polyglutamine Expansion Diseases – the Case of Machado-Joseph Disease

  2007cites this paper
• Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT.

  2007cites this paper
• Applications of Clinical Dopamine Imaging.

  2007cites this paper
• Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17

  2006cites this paper
• Genetic and DAT imaging studies of familial parkinsonism in a Taiwanese cohort.

  2006cites this paper
• Restless legs syndrome and motor activity during sleep in spinocerebellar ataxia type 6.

  2006cites this paper
• Applications of clinical dopamine imaging.

  2006cites this paper
• Homozygous and heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients

  2006cites this paper
• 99mTc‐TRODAT‐1 SPECT study in early Parkinson's disease and essential tremor

  2005cites this paper
• Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6.

  2005influential citation
• SPECT in der Diagnostik von Parkinson-Syndromen

  2004cites this paper
• Defining a metabolic phenotype in the brain of a transgenic mouse model of spinocerebellar ataxia 3.

  2004cites this paper
• Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study

  2004cites this paper
• Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.

  2004cites this paper
• Radiopharmaceuticals for single-photon emission computed tomography brain imaging.

  2003cites this paper
• Spinocerebellar Ataxia 3—Machado-Joseph Disease (SCA3)

  2003cites this paper
• Indexed in Embase/excerpta Medica/elsevier Biobase Krause & Pachernegg Gmbh . Verlag Für Medizin Und Wirtschaft . A-3003 Gablitz Online-datenbank Mit Autoren-und Stichwortsuche Spect in Der Diagnostik Von

  year unknowncites this paper